Rwanda Biomedical Center, Kigali, RwandaKigali, Kigali, Rwanda
Disclosure information not submitted.
176 - Remdesivir for Post-Exposure Prophylaxis of Marburg Virus Disease: A Cohort Study Assessing Safety, Clinical, and Immunologic Outcomes.
Monday, October 20, 20252:45 PM - 2:57 PM US ET